| 1 |
34482638 | Reciprocal epigenetic remodeling controls testicular cancer hypersensitivity to hypomethylating agents and chemotherapy. | 2022 Feb |
5 |
| 2 |
32660355 | Expression of UDP Glucuronosyltransferases 2B15 and 2B17 is associated with methylation status in prostate cancer cells. | 2021 Mar |
1 |
| 3 |
30139210 | Derivative of Stevioside; CPUK02; Restores ESR1 Gene Methylation in MDA-MB 231 | 2018 Aug 24 |
1 |
| 4 |
28090275 | Induction of Epigenetic Alteration by CPUK02, An Ent- kaurenoid Derivative of Stevioside. | 2017 Jan-Mar |
2 |
| 5 |
28462005 | Inhibitors of DNA methylation support TGF-β1-induced IL11 expression in gingival fibroblasts. | 2017 Apr |
1 |
| 6 |
25621113 | Epigenetic therapy of cancer stem and progenitor cells by targeting DNA methylation machineries. | 2015 Jan 26 |
2 |
| 7 |
25746661 | Deregulation of DNMT1, DNMT3B and miR-29s in Burkitt lymphoma suggests novel contribution for disease pathogenesis. | 2015 Apr |
1 |
| 8 |
21359954 | Enhancement of chemotherapeutic efficacy in hypermethylator breast cancer cells through targeted and pharmacologic inhibition of DNMT3b. | 2012 Jan |
1 |
| 9 |
23300844 | Acute hypersensitivity of pluripotent testicular cancer-derived embryonal carcinoma to low-dose 5-aza deoxycytidine is associated with global DNA Damage-associated p53 activation, anti-pluripotency and DNA demethylation. | 2012 |
2 |
| 10 |
21229291 | Epigenetic regulation of DNA methyltransferases: DNMT1 and DNMT3B in gliomas. | 2011 Sep |
1 |
| 11 |
21484930 | DNMT3B gene amplification predicts resistance to DNA demethylating drugs. | 2011 Jul |
1 |
| 12 |
21674861 | Expression analysis of genes involved in epigenetic regulation and apoptosis in human malignant haematopoietic cell lines treated with 5-azacytidine. | 2011 Jan-Mar |
1 |
| 13 |
19951990 | High DNA methyltransferase 3B expression mediates 5-aza-deoxycytidine hypersensitivity in testicular germ cell tumors. | 2009 Dec 15 |
1 |
| 14 |
17325427 | The role of RASSF1A methylation in cancer. | 2007 |
1 |
| 15 |
16951151 | Silencing of the metastasis suppressor RECK by RAS oncogene is mediated by DNA methyltransferase 3b-induced promoter methylation. | 2006 Sep 1 |
1 |